As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for
aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk …

Background Sex-specific characteristics in patients with aortic stenosis and small annuli
undergoing transcatheter aortic valve implantation (TAVI) might affect clinical outcomes and …

BACKGROUND Sex does have an effect on disease perception and outcomes after cardiac
surgery. OBJECTIVES The aim of this study was to quantify the differences in cardiovascular …

aortic valve replacement (TAVR) was born in Rouen, France, on April 16, 2002, and the
earliest solid scientific evidence accrued in the United States with the PARTNER (Placement …

Background/Objectives: Understanding sex-based differences in cardiovascular outcomes is
paramount to improving clinical outcomes. Surgery is an aggressive but effective therapy for …

Aims In recent years, extensive literature has been produced demonstrating inferior
outcomes for women when compared with men undergoing heart valve interventions …

OBJECTIVES We investigated the sex-related difference in characteristics and 2-year
outcomes after surgical aortic valve replacement (SAVR) by propensity-score matching …

Valvular heart disease (VHD) is a major cause of cardiovascular mortality and morbidity
worldwide in both women and men, despite medical and interventional management …

Background The impact of sex on outcomes following surgical aortic valve replacement
(SAVR) remains unclear. It has been proposed that females experience inferior outcomes …